Fatigue in HIV illness: Relationship to depression, physical limitations, and disability

被引:54
作者
Ferrando, S [1 ]
Evans, S [1 ]
Goggin, K [1 ]
Sewell, M [1 ]
Fishman, B [1 ]
Rabkin, J [1 ]
机构
[1] Cornell Univ, Coll Med, Dept Psychiat, New York, NY USA
来源
PSYCHOSOMATIC MEDICINE | 1998年 / 60卷 / 06期
关键词
HIV; AIDS; fatigue; depression; disability;
D O I
10.1097/00006842-199811000-00019
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study was conducted to investigate the prevalence of clinical fatigue reported by gay/bisexual men at all HIV illness stages, and whether fatigue, while associated with depression, independently contributes to limitations in physical function and disability. Method: HIV- men, HIV+ men with CD4 counts >500, HIV+ men with CD4 counts 200 to 500, and men with AIDS were compared on prevalence of clinical fatigue, as defined by a standardized instrument. Among HIV+ men, the relationships among fatigue, depressed mood, major depressive disorder, HIV illness markers (including CD4 count and HIV RNA viral load), physical limitations, and disability were assessed at baseline and after 1 year. Results: The prevalence of clinical fatigue in men with CD4 counts <500 was 14%, significantly higher than HIV- men and HIV+ men with CD4 counts >500. However, fatigue was not directly correlated with CD4 count or HN RNA. Fatigue was a chronic symptom that was associated with depressed mood, major depressive disorder, physical limitations, and disability. After 1 year, an increase in depressive symptoms predicted a small amount of variance in fatigue; however, depressive symptoms were not associated with physical limitations or disability after controlling for fatigue. Conclusion: Fatigue is a chronic symptom that is more prevalent in advanced HIV illness, and which, although associated with depression, does not seem to be merely a symptom of depression. Because fatigue contributes independently to physical limitations and disability, it should be assessed and treated.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 1995, STEDMANS MED DICT
[2]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[3]  
[Anonymous], [No title captured]
[4]  
BATES B, 1995, GUIDE PHYSICAL EXAMI, P33
[5]  
Beck AT, 1961, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004
[6]  
BROOKE RH, 1979, MED CARE S, V17, P20
[7]  
Bruera E, 1989, J Pain Symptom Manage, V4, P3, DOI 10.1016/0885-3924(89)90057-2
[8]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[9]   DEVELOPMENT OF A FATIGUE SCALE [J].
CHALDER, T ;
BERELOWITZ, G ;
PAWLIKOWSKA, T ;
WATTS, L ;
WESSELY, S ;
WRIGHT, D ;
WALLACE, EP .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (02) :147-153
[10]  
COHEN PT, 1994, AIDS KNOWLEDGE BASE